These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21912025)

  • 1. Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome.
    Mohamed GB; Abdel-Latif EA
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):955-62. PubMed ID: 21912025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum osteoprotegerin level in children with nephrotic syndrome and the effect of glucocorticoid on it].
    Li YL; Wang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Sep; 14(9):653-6. PubMed ID: 22989431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteoprotegerin and calcium-phosphorus metabolism parameters in children with chronic renal failure].
    Ziółkowska H; Roszkowska-Blaim M
    Przegl Lek; 2006; 63 Suppl 3():68-71. PubMed ID: 16898492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease.
    Grzegorzewska AE; Młot M
    Rocz Akad Med Bialymst; 2004; 49():190-2. PubMed ID: 15631341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients.
    Cibulka R; Racek J; Pikner R; Rajdl D; Trefil L; Vesela E; Studenovska M; Siroka R
    Calcif Tissue Int; 2007 Aug; 81(2):99-106. PubMed ID: 17622482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.
    Giusti M; Cecoli F; Fazzuoli L; De Franchis V; Ceresola E; Ferone D; Mussap M; Minuto F
    Metabolism; 2007 May; 56(5):699-707. PubMed ID: 17445547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concentration of osteoprotegerin, bone formation and resorption markers in patients with phenylketonuria].
    Ambroszkiewicz J; Gajewska J; Chełchowska M; Ołtarzewski M; Laskowska-Klita T; Nowacka M; Milanowski A
    Pol Merkur Lekarski; 2008 Jul; 25(145):57-60. PubMed ID: 18839616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
    Elwakkad AS; El Elshamy KA; Sibaii H
    Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum osteoprotegerin level is lower in peritoneal dialysis patients than in hemodialysis ones.
    Grzegorzewska AE; Młot M
    Rocz Akad Med Bialymst; 2004; 49():193-6. PubMed ID: 15631342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical bone markers in nephrotic children.
    Biyikli NK; Emre S; Sirin A; Bilge I
    Pediatr Nephrol; 2004 Aug; 19(8):869-73. PubMed ID: 15206021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
    Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
    Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.
    Reyes-García R; Muñoz-Torres M; García DF; Mezquita-Raya P; García Salcedo JA; de Dios Luna J
    Menopause; 2010; 17(1):140-4. PubMed ID: 19574937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status?
    Sypniewska G; Sobanska I; Pater A; Kedziora-Kornatowska K; Nowacki W
    Med Sci Monit; 2010 Feb; 16(2):CR96-101. PubMed ID: 20110921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin and RANKL serum levels and their relationship with serum ghrelin in children with chronic renal failure and on dialysis.
    Ozkaya O; Buyan N; Bideci A; Gonen S; Ortac E; Fidan K; Cinaz P; Söylemezoğlu O
    Nephron Clin Pract; 2007; 105(4):c153-8. PubMed ID: 17259742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
    Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
    J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women.
    Holecki M; Zahorska-Markiewicz B; Janowska J; Nieszporek T; Wojaczyńska-Stanek K; Zak-Gołab A; Wiecek A
    Obesity (Silver Spring); 2007 Aug; 15(8):1925-9. PubMed ID: 17712108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.